SOM vs SPL

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

SOM

SOMNOMED FPO [SOM]

55MEDIUM

SPL

STARPHARMA FPO [SPL]

56MEDIUM

Score Breakdown

SOM SPL
Technical
59
58
Catalyst
55
68
Sentiment
50
50
Fundamental
86
58
Momentum
36
63
Risk Gate
45
50

Key Metrics

SOM Metric SPL
$75.8MMarket Cap$345.9M
59KAvg Volume (20d)2.9M
N/AShort Interest+0.0%
$0.94552-Week High$0.815
$0.30052-Week Low$0.110
-2.8%Daily Change+2.1%
$0.345Reference Price$0.735
-5.7%ROE-45.6%
-2.3%Profit Margin-58.9%

Active Signals

SOM Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.7x)
Revenue declining (-7%)

SPL Signals

Stochastic just turned bullish from a low level — early reversal sign
Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (14 quarters)
Revenue in sharp decline (-56%)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare SOM and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVE vs NEU →AVE vs SOM →AVE vs DOC →NEU vs SOM →DOC vs NEU →
SOM Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).